Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions.
about
Back to basics: pitting edema and the optimization of hypertension treatment in incident peritoneal dialysis patients (BRAZPD)Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis.Blood pressure in haemodialysis patients: the importance of the relationship between the renin-angiotensin-aldosterone system, salt intake and extracellular volume.Nitric Oxide Resistance Reduces Arteriovenous Fistula Maturation in Chronic Kidney Disease in RatsOptimal blood pressure level and best measurement procedure in hemodialysis patients.Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial.Associations between coronary calcification on chest radiographs and mortality in hemodialysis patients.The management of hypertension in hemodialysis and CAPD patients.The assessment of oxidative stress on patients with chronic renal failure at different stages and on dialysis patients receiving different hypertensive treatmentIndices of activity of the nitric oxide system in hemodialysis patientsCoronary-artery calcium scores using electron beam CT in patients with chronic renal failure.Renal denervation--implications for chronic kidney disease.Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists.Does pharmacotherapy improve cardiovascular outcomes in hemodialysis patients?Platelet activation and secretion in patients with major depression, thoracic aortic atherosclerosis, or renal dialysis treatment.Potential cardiovascular risk factors in paediatric renal transplant recipients.Cardioprotective effect of renalase in 5/6 nephrectomized rats.Safety and Efficacy of Losartan 50 mg in Reducing Blood Pressure among Patients with Post-Dialysis Euvolemic Hypertension: A Randomized Control Trial.Dialysate sodium prescription and blood pressure in hemodialysis patients.Maintenance of negative fluid balance can improve endothelial and cardiac functions in primary hypertensive patients.Pharmacokinetics of Aliskiren in Patients with End-Stage Renal Disease Undergoing Haemodialysis
P2860
Q28729712-0FDD3F85-B8F7-4B0B-A169-BE5231EC7A0AQ33615328-62947EBF-56D7-4717-9BA3-4D30812855ADQ35770237-F19DEF99-D195-47B8-925A-1CF17AE47CB8Q35884072-0F9250E9-F420-434F-8138-ADA904C69214Q36012839-3A0E8904-6821-4159-B1A0-521D906EA115Q36383953-78D68BAA-DC69-4047-BDA0-00006ECACB96Q36392835-CA54DACD-2911-4D19-A768-606827848CD0Q36908011-A7E0C3CE-A3A6-45F6-B48F-E1228DA24F79Q37199405-8AC7784B-A576-477A-A29D-56D256F4BB13Q37374542-CA013535-7C65-4381-A373-12B2C4C14408Q37425869-5CAED146-EFB1-4E8B-8F6A-E1D4352F2117Q38204682-9597998E-35AB-4EA0-8983-2B9EAD33DDD5Q38560705-0799AF3C-E55B-46F8-8A7A-F4E18CDCD201Q38602442-D28388E7-7982-413F-A995-0D921511E71CQ40641442-A5B69278-38F4-49A5-B476-14C793F37047Q46776593-A935A70C-68CA-4330-8825-5E5AB8FE1E57Q46790626-0720097A-2110-4618-A549-54C63C8E057CQ47105380-F8C95D70-6902-4E44-8C7C-F0FBAA330DF9Q53093124-085FF2CB-FE6C-45AD-AB70-83A0A55F308AQ53736632-7858A1D0-6FA5-4DDC-AED5-47C1462E9C8EQ56987287-C774A60D-622D-42F5-A94D-62D11A007FC6
P2860
Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Hypertension in the ESRD patie ...... tcomes, and future directions.
@en
type
label
Hypertension in the ESRD patie ...... tcomes, and future directions.
@en
prefLabel
Hypertension in the ESRD patie ...... tcomes, and future directions.
@en
P1476
Hypertension in the ESRD patie ...... tcomes, and future directions.
@en
P2093
P304
P356
10.1016/S0272-6386(98)70146-5
P577
1998-11-01T00:00:00Z